Annual report
7932.TEDINET S100YIZ2
Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥49.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥49.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥39.3bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥4.2bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥3.6bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.2bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.7bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.9bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.8bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.9bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥70.1bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥70.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥72.4bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥69.6bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥68.4bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥28.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥29.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥41.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥40.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥38.3bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥35.1bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥34.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.8bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.6bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥395m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥815m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥580m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥821m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥917m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥993.45 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥854.46 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥886.04 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥406.79 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥397.95 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥14,682.9 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥13,853.4 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥13,081.12 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥11,982.71 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥11,617.32 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 58.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.8% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.5% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.5% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 630 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 640 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 627 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 611 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 602 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥29.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥29.7bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥30.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥27.9bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.9bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥2.4bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.5bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥695m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.2bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.6bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥1.8bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.8bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥677m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥996m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥58.7bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥57.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥59.7bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥58.4bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥58.7bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥23.6bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥24.5bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥35.1bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥33.4bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥32.0bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥29.9bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥29.4bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥1,266.14 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥640.17 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥628.42 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥235.6 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥346.61 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥696 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥600 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥220 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥12,550.43 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥11,601.5 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥11,130.7 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥10,383.28 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥10,216.1 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.8% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.0% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.5% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,889,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 466 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 471 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 449 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 428 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 418 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 94
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥22m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥128m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥1.9bn |
| Collagen Casing And Materialreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥169m |
| Collagen Casing And Materialreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥548m |
| Collagen Casing And Materialreportable segment | employees | at 2026-03-31 | 336 pure |
| Collagen Casing And Materialreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥9.2bn |
| Collagen Casing And Materialreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥9.2bn |
| Collagen Casing And Materialreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥812m |
| Cosmeticsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥4m |
| Cosmeticsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥23m |
| Cosmeticsreportable segment | employees | at 2026-03-31 | 53 pure |
| Cosmeticsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥8.3bn |
| Cosmeticsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥8.3bn |
| Cosmeticsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.3bn |
| Foodstuff And Otherreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥380m |
| Foodstuff And Otherreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥77m |
| Foodstuff And Otherreportable segment | employees | at 2026-03-31 | 58 pure |
| Foodstuff And Otherreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥10.3bn |
| Foodstuff And Otherreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥10.3bn |
| Foodstuff And Otherreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥567m |
| Gelatin And Peptide Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥38m |
| Gelatin And Peptide Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥180m |
| Gelatin And Peptide Relatedreportable segment | employees | at 2026-03-31 | 94 pure |
| Gelatin And Peptide Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥12.6bn |
| Gelatin And Peptide Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥12.6bn |
| Gelatin And Peptide Relatedreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥4m |
| Gelatin And Peptide Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.4bn |
| Leather Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2m |
| Leather Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥21m |
| Leather Relatedreportable segment | employees | at 2026-03-31 | 43 pure |
| Leather Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥5.9bn |
| Leather Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥5.9bn |
| Leather Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥167m |
| Real Estate And Leasereportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3m |
| Real Estate And Leasereportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥0 |
| Real Estate And Leasereportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥827m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥596m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥855m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥47.3bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥47.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥5m |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥6.1bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥39m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥174m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Collagen Casing And Materialreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥174m |
| Collagen Casing And Materialreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥691m |
| Collagen Casing And Materialreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥9.3bn |
| Collagen Casing And Materialreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥9.3bn |
| Collagen Casing And Materialreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Cosmeticsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥13m |
| Cosmeticsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥43m |
| Cosmeticsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥7.7bn |
| Cosmeticsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥7.7bn |
| Cosmeticsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Foodstuff And Otherreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥208m |
| Foodstuff And Otherreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥86m |
| Foodstuff And Otherreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥10.6bn |
| Foodstuff And Otherreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥10.6bn |
| Foodstuff And Otherreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥591m |
| Gelatin And Peptide Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥36m |
| Gelatin And Peptide Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥253m |
| Gelatin And Peptide Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥13.2bn |
| Gelatin And Peptide Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥13.2bn |
| Gelatin And Peptide Relatedreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥3m |
| Gelatin And Peptide Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Leather Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥15m |
| Leather Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥21m |
| Leather Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Leather Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Leather Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥210m |
| Real Estate And Leasereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥7m |
| Real Estate And Leasereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3m |
| Real Estate And Leasereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Real Estate And Leasereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥837m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥456m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥49.1bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥49.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4m |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥5.4bn |
| Collagen Casing And Materialreportable segment | employees | at 2026-03-31 | 298 pure |
| Cosmeticsreportable segment | employees | at 2026-03-31 | 5 pure |
| Foodstuff And Otherreportable segment | employees | at 2026-03-31 | 31 pure |
| Gelatin And Peptide Relatedreportable segment | employees | at 2026-03-31 | 91 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,819
| Item | Context | Value | Unit |
|---|---|---|---|
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)江崎グリコ㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)㈱りそなホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)プリマハム㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)明治ホールディングス㈱(注３) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Original text (Japanese)㈱三井住友フィナンシャルグループ(注３) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Original text (Japanese)㈱ＴＯＫＡＩホールディングス(注３) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Original text (Japanese)有 | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row2Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row3Member | Text · Plus | |
| Basic policy on human resources strategy employees etc (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)㈱ニッピコラーゲン化粧品 | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |